Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: http://dx.doi.org/10.25673/101285
Titel: NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery : a prospective observational study
Autor(en): Elitok, SabanIn der Gemeinsamen Normdatei der DNB nachschlagen
Devarajan, Prasad
Bellomo, RinaldoIn der Gemeinsamen Normdatei der DNB nachschlagen
Isermann, BerendIn der Gemeinsamen Normdatei der DNB nachschlagen
Haase, MichaelIn der Gemeinsamen Normdatei der DNB nachschlagen
Haase-Fielitz, AnjaIn der Gemeinsamen Normdatei der DNB nachschlagen
Erscheinungsdatum: 2022
Art: Artikel
Sprache: Englisch
URN: urn:nbn:de:gbv:ma9:1-1981185920-1032406
Schlagwörter: Cardiopulmonary bypass
Cardiorenal syndrome
NGAL/hepcidin-25 ratio
Subclinical AKI
Zusammenfassung: Background Acute kidney injury (AKI) subtypes combining kidney functional parameters and injury biomarkers may have prognostic value. We aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL)/hepcidin-25 ratio (urinary concentrations of NGAL divided by that of hepcidin-25) defined subtypes are of prognostic relevance in cardiac surgery patients. Methods We studied 198 higher-risk cardiac surgery patients. We allocated patients to four groups: Kidney Disease Improving Global Outcomes (KDIGO)-AKI-negative and NGAL/hepcidin-25 ratio-negative (no AKI), KDIGO AKI-negative and NGAL/hepcidin-25 ratio-positive (subclinical AKI), KDIGO AKI-positive and NGAL/hepcidin-25 ratio-negative (clinical AKI), KDIGO AKI-positive and NGAL/hepcidin-25 ratio-positive (combined AKI). Outcomes included in-hospital mortality (primary) and long-term mortality (secondary). Results We identified 127 (61.6%) patients with no AKI, 13 (6.6%) with subclinical, 40 (20.2%) with clinical and 18 (9.1%) with combined AKI. Subclinical AKI patients had a 23-fold greater in-hospital mortality than no AKI patients. For combined AKI vs. no AKI or clinical AKI, findings were stronger (odds ratios (ORs): 126 and 39, respectively). After adjusting for EuroScore, volume of intraoperative packed red blood cells, and aortic cross-clamp time, subclinical and combined AKI remained associated with greater in-hospital mortality than no AKI and clinical AKI (adjusted ORs: 28.118, 95% CI 1.465–539.703; 3.737, 95% CI 1.746–7.998). Cox proportional hazard models found a significant association of biomarker-informed AKI subtypes with long-term survival compared with no AKI (adjusted ORs: pooled subclinical and clinical AKI: 1.885, 95% CI 1.003–3.542; combined AKI: 1.792, 95% CI 1.367–2.350). Conclusions In the presence or absence of KDIGO clinical criteria for AKI, the urinary NGAL/hepcidin-25-ratio appears to detect prognostically relevant AKI subtypes.
URI: https://opendata.uni-halle.de//handle/1981185920/103240
http://dx.doi.org/10.25673/101285
Open-Access: Open-Access-Publikation
Nutzungslizenz: (CC BY 4.0) Creative Commons Namensnennung 4.0 International(CC BY 4.0) Creative Commons Namensnennung 4.0 International
Sponsor/Geldgeber: Projekt DEAL 2021
Journal Titel: Journal of nephrology
Verlag: Springer
Verlagsort: Milano
Band: 35
Heft: 2
Originalveröffentlichung: 10.1007/s40620-021-01063-5
Seitenanfang: 597
Seitenende: 605
Enthalten in den Sammlungen:Medizinische Fakultät (OA)

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
Elitok et al._NGAL-hepcidin-25_2022.pdfZweitveröffentlichung1.81 MBAdobe PDFMiniaturbild
Öffnen/Anzeigen